LifeMD, Inc.'s (NASDAQ:LFMD) Market Cap Dropped US$62m Last Week; Individual Investors Who Hold 43% Were Hit as Were Institutions
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating
LifeMD to Participate in Three Investor Conferences During November
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
LifeMD Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
LifeMD Analyst Ratings
Strong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite Challenges
LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript Summary
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating, Announces Target Price $16
B.Riley Financial Maintains LifeMD(LFMD.US) With Buy Rating, Raises Target Price to $12
B. Riley Adjusts Price Target on LifeMD to $12 From $11, Maintains Buy Rating
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ...
10-Q: Q3 2024 Earnings Report
LifeMD Non-GAAP EPS of $0.14 Beats by $0.07, Revenue of $53.4M Misses by $0.4M
Earnings Flash (LFMD) LIFEMD Posts Q3 Revenue $53.4M
Express News | LifeMD Shares up 9.2% After the Bell Following Results
Express News | LifeMD Q3 Gross Margin 90.6%
Express News | LifeMD Q3 Revenue USD 53.4 Million Vs. IBES Estimate USD 53.8 Million
Express News | LifeMD Outlook FY Adjusted Ebitda USD 13-14 Million
LifeMD Q3 2024 Earnings Preview